Global gross expenditures on R&D (GERD) are estimated to increase 2.7% in 2013 to $1,558 billion in terms of purchasing power parity, or 1.8% of GDP. In 2014, GERD is expected to grow 3.9%. The top 10 countries accounted for about 80% of GERD. Asia, the Americas, Europe and Rest of World accounted for 38%, […]
An analysis of the 12 largest research-based biopharmaceutical firms found that, between 2010 and 2013, these companies did not refill their drug pipelines at a sufficient rate to compensate for the new drugs released, the failure of compounds in development, and lower sales forecasts for compounds in late-stage development. Consequently, the value of their drug […]
The FDA has released finalized guidance on the distribution of IVD products. IVD products for the lab research phase of development may be commercialized if they are labeled, “For Research Use Only [RUO]. Not for use in diagnostic procedures.” Investigational devices shipped for testing prior to commercial marketing must be labeled, “For Investigational Use Only […]
The International Energy Agency (IEA) stated that Middle East producers’ delay in new oil production investments could lead to higher oil prices due to supply shortages. Although it forecasts the US to become the largest producer of oil worldwide by 2015, the IEA expects US production to decline after 2020. Some Middle Eastern nations have […]
Worldwide expenditures on medicines is forecast to increase 3%–6% between 2013 and 2017 to $1,170–$1,200 billion, excluding off-invoice discounts and rebates. Spending in developed countries is estimated to grow 1%–4% to $650–$680 billion. Spending in pharmerging markets will increase 10%–13% to $370–$400 billion, with spending in China estimated to grow 14%–17% to $160–$190 billion. Spending […]
The Centers for Medicare and Medicaid Services (CMS) finalized pricing for new, analyte-specific molecular codes in late September. Compared to the former stacked code system, which did not list prices for individual tests, the average price of the new codes is 26% higher and the mean price is 25% higher. However, the median price declined […]
The FDA announced this month a proposal to eliminate artificial trans fats that are found in processed foods, such as cookies and frozen pizza. The proposal would classify artificial trans fats as a food additive, and thus requiring regulatory approval. Since 2006, the FDA has required that artificial trans fats be cited on food labels, […]
An October survey of 74 US public and private research universities by the Association of American Universities, the Association of Public and Land-grant Universities (APLU), and the Science Coalition sheds new light on the effects of the US federal budget sequestration, which began in March. Eighty-one percent of respondents reported that the sequestration had an […]
Company Announcements In August, Agilent Technologies gave an Agilent Thought Leader Award to Dr. Emmanuel Barillot, director of Bioinformatics and Systems IT at the Institute Curie in Paris, in recognition of his development of user friendly, Web-based bioinformatics tools for systems toxicology. Agilent Technologies opened in August the $25 million Spectroscopy Technology Innovation Center in […]
Following the 16-day closure of the US federal government, science agencies are catching up on grant reviews. At the NIH, 200 review panels were canceled, affecting the ranking of 11,000 grant applications. In response to researchers’ pleas, the agency will reschedule the panel meetings for the next two months. The NSF was forced to cancel […]
Pay Invoice
Latest Blogs
-
New Report Details Higher Education Science R&D Spending
February 27, 2026 3:23 pm
-
Single Use Leads Bioreactor Market Growth
December 30, 2025 6:04 pm
Sitemap
Your Data and Privacy
About Us
IBO (Instrument Business Outlook) is a twice-monthly newsletter aimed at providing decision-makers with the latest and most complete information available on the life science and analytical instrument industry, and lab product markets. IBO delivers the latest curated industry news, information and trends, as well as SDi data and analysis to deliver the maximum in industry insight with a minimum time investment for executives and investors.
